✦ LIBER ✦

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials

✍ Scribed by Dan Rudin; Sooraj M. Shah; Alexander Kiss; Robert V. Wetz; Vincent M. Sottile

Book ID: 111237753
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 119 KB
Volume: 27
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2007.01580.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine and interferon versus lamivud

Lamivudine and interferon versus lamivudine monotherapy for HBeAg-Positive hepatitis B treatment: A meta-analysis of randomized, controlled trials

✍ Dan Rudin 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB

Lamivudine and 24 weeks of lamivudine/in

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

✍ Eugene R Schiff; Jules L Dienstag; Selim Karayalcin; Ian S Grimm; Robert P Perri 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Lamivudine vs lamivudine and interferon

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

✍ C. Yurdaydin; H. Bozkaya; H. Çetinkaya; T. Şahin; D. Karaoğuz; M. Törüner; Ö. Er 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m